Kuros Bioscience Ltd.
No trades
Fundamentals and stats
Kuros Bioscience Ltd. financial statements, including revenue, expenses, and profit
The total revenue of CSBTF for the last semiannual is 80.01 M USD, and it's 66.24% higher compared to the previous semiannual. The net income of H1 25 is -2.54 M USD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
TTM